rescriptor

Frequently asked questions

What does Rescriptor treat?

Rescriptor (Delavirdine Mesylate) may be used to treat acquired immunodeficiency syndrome, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Rescriptor?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Rescriptor. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Rescriptor?

Rescriptor is marketed by Viiv Hlthcare. You can see Viiv Hlthcare's full profile, rating, and other products on pharmaranks.

Is Rescriptor a brand-name or generic drug?

Rescriptor is a brand-name product with the active ingredient Delavirdine Mesylate.

Is Rescriptor available over the counter?

No. Rescriptor is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Rescriptor come in?

Rescriptor is currently marketed as tablet, per the FDA's National Drug Code Directory.

Is Rescriptor FDA-registered?

Rescriptor is on record with the U.S. FDA under application number NDA020705. You can verify this on its official FDA label.